Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
Dr. Xinyang Hu delivered a special lecture during QICC 2020 on the clinical significance of non-invasive CT-FFR.
The European Society of Cardiology (ESC) Congress 2020 revealed opportunities and challenges in cardiovascular imaging AI.
ESC Updated Guidelines on Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
The European Society of Cardiology published new clinical practice guidelines on managing acute coronary syndromes in patients.
Keya Medical announced on Aug. 13 that it has raised over $20 million in Series B+ funding.
CuraCloud scientists presented research results on simultaneously classifying and segmenting intracranial hemorrhage using deep learning at ISBI 2020.
DeepVessel FFR was successfully implemented in Luohe Sixth People’s Hospital.
The National Medical Products Administration (NMPA) in China has published new documents regarding the approval of medical AI products.
The SIIM Annual Meeting has been a useful checkpoint for comparing predicted trends with what has actually happened. Read Ed Butler’s expectations for the event.
CuraCloud announced that the U.S. FDA has allowed the clinical use of its deep learning algorithm for the detection and prioritization of incidental pneumonia findings associated with COVID-19.
This article explains some of the potential challenges with applying AI to chest x-ray.
CuraCloud announced today that its computer-aided triage and notification system for the early recognition of ICH has receive clearance from the U.S. FDA.
On March 20, the research results of Keya Medical’s COVID-19 AI Assisted Diagnosis algorithm were published in the peer-reviewed journal Radiology.